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A sclerosing stromal tumor of the ovary with 
masculinization in a premenarchal girl
A sclerosing stromal tumor of the ovary is an extremely rare benign 
tumor; it usually is found during the second and third decades of 
life. Patients present with pelvic pain or a palpable abdominal mass. 
Hormonal effects such as masculinization are uncommon. Here, an 
11-year old premenarchal girl presented with deepening of the voice. 
In addition, clitoromegaly and hirsutism with a male suprapubic 
hair pattern were observed. The laboratory findings showed that the 
testosterone level was elevated to 3.67 ng/mL, andostenedione to 
above 10 ng/mL, dehydroepiandrosterone-sulfate to 346 µg/dL and 
17-hydroxy progesterone (17-OHP) to 11.28 ng/mL. The chromosome 
evaluation revealed a 46,XX female karyotype. An adrenocorticotropic 
hormone stimulation test was performed. The 17-OHP to cortisol 
ratio in 30 minutes was 0.045, which suggested a heterozygote for the 
21-hydroxylase deficiency. However, the CYP21A2 gene encoding 
steroid 21-hydroxylase showed normal. The pelvic ultrasound showed 
a heterogeneous mass consisting of predominantly solid tissue in the 
pelvic cavity. The pelvic magnetic resonance imaging revealed an 8.9×
6.2×6.6 cm mass of the left ovary. A left oophrectomy was performed 
and microscopic examination confirmed a sclerosing stromal tumor. 
Immunohistochemical studies showed that the tumor was positive 
for smooth muscle actin and vimentin, but negative for S-100 protein 
and cytokeratin. Following surgery, the hormone levels returned to the 
normal range and the hirsutism resolved.
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reported
2). The tumor occurs predominantly during the second 
and third decades of life with a mean age of 28 years
3). Most of 
the reported cases have described women 14 years of age or older 
that have undergone menarche, except for three cases involving 
premenarchal girls
2­4). The common presenting clinical symptoms are 
Introduction
A sclerosing stromal tumor (SST) of the ovary is a rare benign 
subtype of a sex cord stromal tumor. Since its first description in 
1973 by Chalvardjian and Scully
1), fewer than 100 cases have been Korean J Pediatr 2011;54(5):224-227 • DOI: 10.3345/kjp.2011.54.5.224    225
pelvic pain, hypermenorrhea, and menstrual irregularities. Although 
these tumors were initially believed to be non­functional
1,5), there 
have been more recent reports suggesting the presence of hormone 
production both from a biochemical standpoint and the associated 
manifestations of infertility and irregular menses
6). Hormonal effects 
such as masculinization are uncommon. Two cases of SSTs with 
virilization have been reported, both were pregnant women
7,8). Here, 
an atypical case of an SST of the ovary with virilization is reported in 
a premenarchal girl.
Case report
An 11­year­old premenarchal girl presented to the hospital with 
deepening of the voice and hirsutism, which was reported to have 
started about one year ago. Physical examination showed a male 
suprapubic hair pattern and 1 cm sized enlarged clitoris. The Tanner 
stage was II for breast and V for pubic hair development. The bone 
age was 13 years of age, advanced compared to the chronological 
age. The laboratory findings showed that the testosterone level 
was elevated to 3.67 ng/mL (normal range, 0.2 to 0.38 ng/mL), 
andostenedione to above 10 ng/mL (maximum level 1.7 ng/mL), 
dehydroepiandrosterone­sulfate (DHEA­S) to 346 μg/dL (normal 
range, 34 to 129 μg/dL) and 17­hydroxy progesterone (17­OHP) to 
11.28 ng/mL (normal range, 0.2 to 2.65 ng/mL). The chromosome 
evaluation revealed a 46,XX female karyotype. The impression was 
non­classical congenital adrenal hyperplasia. An adrenocorticotropic 
hormone stimulation test (15 μg/kg bolus i.v.) was performed. The 
17­OHP to cortisol ratio in 30 minutes was 0.045, which suggested 
a heterozygote for the 21­hydroxylase deficiency. However, the 
CYP21A2 genetic studies were normal. 
The pelvic ultrasound showed an 8.5×5.9 cm mass in the left 
pelvic cavity. For further evaluation of the mass and adnexa, 
magnetic resonance imaging (MRI) was carried out and revealed 
an 8.9×6.2×6.6 cm well­defined mass of the left ovary (Fig. 1). The 
patient was diagnosed as having an ovarian tumor with suspicion of 
a sex­cord stromal tumor. A left oophorectomy was performed. On 
gross inspection, the removed left ovarian mass measured 9×7.5×6 
cm and weighed 182 g. The mass was yellow to pink in color and had 
a smooth and well­encapsulated surface. On cut sections, the mass 
was solid with a rubbery consistency. Neither definite necrosis nor 
hemorrhage was present. Microscopic examination showed cellular 
portions with fibroblasts, rounded vacuolated cells and prominent 
thin walled vessels, as well as edematous and collagenous hypocellular 
areas (Fig. 2A, B). Immunohistochemical staining was positive for 
vimentin, smooth muscle actin, and α ­inhibin, but negative for 
S­100 protein and cytokeratin (Fig. 2C, D). Following surgery, the 
hormone levels recovered to the normal range, testosterone to 0.12 
ng/mL, andostenedione to 1.3 ng/mL, DHEA­S to 85.7 μg/dL and 
17­OHP to 0.54 ng/mL. Three months after the surgery, the patient 
had menarche. The development of the breasts was normal and the 
hirsutism with a male suprapubic hair pattern decreased on the six 
month follow­up.
Discussion
Children and adolescents account for only 1% of all tumors in girls 
younger than 17 years, and sex cord stromal tumors constitute 10% 
of pediatric ovarian neoplasms
3,9). SSTs of the ovary are extremely 
rare benign neoplasms that occur early in life (80% occurring in 
second and third decades), in contrast to other stromal tumors that 
commonly occur during the fifth and sixth decades
1,2). 
Most SSTs are hormonally inactive. Chalvardjian and Scully
1) 
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Fig. 1. Magnetic resonance imaging of a large ovarian tumor (arrows). (A) Axial T2-weighted image 
shows about a 9x6 cm well-circumscribed hypointense mass in the pelvic cavity, arised from left 
ovary. (B) Axial Gd-enhanced T1-weighted image demonstrates strong contrast enhancement of 
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originally considered ovarian SSTs to be nonfunctioning tumors. 
However, some investigators have reported endocrine changes 
associated with secretion of estrogen and progesterone
10) as wells as 
induction of precocious puberty
11). Other symptoms include: pelvic 
pain, a palpable pelvic mass, metrorrhagia and menstrual irregularities 
including postmenopausal bleeding in elderly patients. Hormonal 
effects such as masculinization are uncommon. Two cases of SST 
with virilization have been reported, and they were both pregnant 
women
7,8). They were virilized at 10 to 14­16 weeks of gestation; the 
testosterone, DHEA­S, and androstenedione levels were elevated
7,8). 
The case reported here is a unique case of an SST presenting with 
masculinization in an 11 year­old premenarchal girl. The patient had 
Tanner II breast and Tanner V male suprapubic hair development. 
In addition, there were elevated hormonal levels of testosterone, 
andostenedione, and DHEA­S. After resection of the tumor, the 
hormone levels returned to the normal range and the hirsutism 
resolved. Three months after surgery, the patient had spontaneous 
menarche. Ultrasonography is a useful initial tool for differentiating 
between cystic and solid masses and determining the organ of origin. 
However, computed tomography and MRI are both more sensitive 
for delineating the nature of the mass and tumor extension. On 
MRI, a diagnosis of SST can be strongly suggested, when typical 
signal patterns such as hypointense nodules, hyperintense stroma, 
lobulation, strong enhancement with gadolinium and a peripheral 
hypointense rim are present
12).
The differential diagnosis of SSTs of the ovary includes other sex 
cord stromal tumors such as fibromas and thecomas. These may 
be differentiated from the SST on the basis of histopathology and 
immunohistochemical findings
2). The histopathology of the SST 
shows a pseudolobular pattern of cellular areas and hypocellular, 
edematous or collagenous areas; it has a prominent vasculature; and 
prominent sclerosis around clusters of individual cells; as well as cellular 
heterogeneity of the vacuolated luteinized theca­like cells and spindle­
shaped fibroblast­like cells in the cellular areas
1). Pseudolobulation 
and prominent vasculature are extremely rare in luteinized thecomas 
and fibromas
1). Immunohistochemically, the cells of SSTs are positive 
for vimentin, smooth muscle actin, α ­inhibin, and CD99; and are 
negative for S­100 protein and epithe  lial markers
2). The excised 
tumor of the patient reported here showed cellular portions with 
fibroblasts, rounded vacuolated cells, prominent vessels, edematous 
and collageneous hypocellular areas. Immunohistochemical studies 
were positive for vimentin, smooth muscle actin, and α ­inhibin, but 
negative for S­100 protein and cytokeratin.
The SST presented here was atypical as it showed virilization 
in a premenarchal girl. Additional cases, especially those studied 
hormonally, may help detailed understanding for clinical mani­
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Fig. 2. Histologic findings of sclerosing stromal tumor. (A) The tumor shows an alternative pseudolo-
bular pattern constiting of cellular and hypocellular areas (H&E, x100). (B) The cellular area is 
composed of vacuolated cells and spindled fibroblast-like cells (H&E, x400). Immunohistochemically, 
the tumor cells are positive for smooth muscle actin (C, x200) and α-inhibin (D, x200).Korean J Pediatr 2011;54(5):224-227 • DOI: 10.3345/kjp.2011.54.5.224    227
festations of SST of the ovary.
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